Antibody and Recombinant Protein CDMO and Forecast Market

List of Tables
Table 1. Antibody and Recombinant Protein CDMO Market Opportunities & Trends in Global Market
Table 2. Antibody and Recombinant Protein CDMO Market Drivers in Global Market
Table 3. Antibody and Recombinant Protein CDMO Market Restraints in Global Market
Table 4. Key Players of Antibody and Recombinant Protein CDMO in Global Market
Table 5. Top Antibody and Recombinant Protein CDMO Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Antibody and Recombinant Protein CDMO Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Antibody and Recombinant Protein CDMO Revenue Share by Companies, 2017-2022
Table 8. Global Companies Antibody and Recombinant Protein CDMO Product Type
Table 9. List of Global Tier 1 Antibody and Recombinant Protein CDMO Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibody and Recombinant Protein CDMO Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Antibody and Recombinant Protein CDMO Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Antibody and Recombinant Protein CDMO Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Antibody and Recombinant Protein CDMO Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Antibody and Recombinant Protein CDMO Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Antibody and Recombinant Protein CDMO Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Antibody and Recombinant Protein CDMO Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2023-2028
Table 30. Batavia Biosciences Corporate Summary
Table 31. Batavia Biosciences Antibody and Recombinant Protein CDMO Product Offerings
Table 32. Batavia Biosciences Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 33. Grifols Corporate Summary
Table 34. Grifols Antibody and Recombinant Protein CDMO Product Offerings
Table 35. Grifols Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 36. Cerbios-Pharma SA Corporate Summary
Table 37. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offerings
Table 38. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 39. HALIX Corporate Summary
Table 40. HALIX Antibody and Recombinant Protein CDMO Product Offerings
Table 41. HALIX Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 42. Biovian Oy Corporate Summary
Table 43. Biovian Oy Antibody and Recombinant Protein CDMO Product Offerings
Table 44. Biovian Oy Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 45. Catalent Corporate Summary
Table 46. Catalent Antibody and Recombinant Protein CDMO Product Offerings
Table 47. Catalent Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 48. Goodwin Biotechnology Corporate Summary
Table 49. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Product Offerings
Table 50. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 51. Merck Corporate Summary
Table 52. Merck Antibody and Recombinant Protein CDMO Product Offerings
Table 53. Merck Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 54. Hangzhou Hs-biopharm Corporate Summary
Table 55. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Product Offerings
Table 56. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 57. Wuxibiologics Corporate Summary
Table 58. Wuxibiologics Antibody and Recombinant Protein CDMO Product Offerings
Table 59. Wuxibiologics Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 60. Bioinnobio Corporate Summary
Table 61. Bioinnobio Antibody and Recombinant Protein CDMO Product Offerings
Table 62. Bioinnobio Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 63. Thousand Oaks Biopharmaceuticals Corporate Summary
Table 64. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Product Offerings
Table 65. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 66. Cerbios-Pharma SA Corporate Summary
Table 67. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offerings
Table 68. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 69. Eurogentec Corporate Summary
Table 70. Eurogentec Antibody and Recombinant Protein CDMO Product Offerings
Table 71. Eurogentec Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 72. HJB Corporate Summary
Table 73. HJB Antibody and Recombinant Protein CDMO Product Offerings
Table 74. HJB Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 75. Bibo Pharma Corporate Summary
Table 76. Bibo Pharma Antibody and Recombinant Protein CDMO Product Offerings
Table 77. Bibo Pharma Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 78. MabPlex International Corporate Summary
Table 79. MabPlex International Antibody and Recombinant Protein CDMO Product Offerings
Table 80. MabPlex International Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 81. Genscriptprobio Corporate Summary
Table 82. Genscriptprobio Antibody and Recombinant Protein CDMO Product Offerings
Table 83. Genscriptprobio Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 84. Vetter Corporate Summary
Table 85. Vetter Antibody and Recombinant Protein CDMO Product Offerings
Table 86. Vetter Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 87. Etinpro (Beijing) Co Corporate Summary
Table 88. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Product Offerings
Table 89. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 90. Boehringer Ingelheim BioXcellence Corporate Summary
Table 91. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Product Offerings
Table 92. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 93. Lonza Corporate Summary
Table 94. Lonza Antibody and Recombinant Protein CDMO Product Offerings
Table 95. Lonza Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 96. 3SBio Inc Corporate Summary
Table 97. 3SBio Inc Antibody and Recombinant Protein CDMO Product Offerings
Table 98. 3SBio Inc Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
Table 99. Porton Corporate Summary
Table 100. Porton Antibody and Recombinant Protein CDMO Product Offerings
Table 101. Porton Antibody and Recombinant Protein CDMO Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Antibody and Recombinant Protein CDMO Segment by Type in 2021
Figure 2. Antibody and Recombinant Protein CDMO Segment by Application in 2021
Figure 3. Global Antibody and Recombinant Protein CDMO Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antibody and Recombinant Protein CDMO Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antibody and Recombinant Protein CDMO Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antibody and Recombinant Protein CDMO Revenue in 2021
Figure 8. By Type - Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
Figure 9. By Application - Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
Figure 10. By Region - Global Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
Figure 11. By Country - North America Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
Figure 12. US Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
Figure 16. Germany Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 17. France Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
Figure 24. China Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 28. India Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
Figure 30. Brazil Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Antibody and Recombinant Protein CDMO Revenue Market Share, 2017-2028
Figure 33. Turkey Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Antibody and Recombinant Protein CDMO Revenue, (US$, Mn), 2017-2028
Figure 37. Batavia Biosciences Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Grifols Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. HALIX Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Biovian Oy Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Catalent Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Wuxibiologics Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bioinnobio Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Eurogentec Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. HJB Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Bibo Pharma Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. MabPlex International Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Genscriptprobio Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Vetter Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Lonza Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. 3SBio Inc Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Porton Antibody and Recombinant Protein CDMO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)